
Sign up to save your podcasts
Or


In this episode of Bulletproof Radio, my guest is known as "the woman who wants to genetically engineer you," and a leading voice for genetic cures.
Liz Parrish founded and serves as CEO of BioViva Sciences USA Inc., a bioinformatics company actively working to extend healthy lifespans using gene therapy. It’s looking specifically at how gene therapy works in humans and how regenerative genes work in human bodies. Its partner company, Integrative Health Systems, helps people get access to these technologies today.
A strong champion of progress and education for the advancement of gene therapy, Liz firmly supports our right and our ability to hack our own DNA.
And she definitely walks her talk: In 2015 she became the first person in the world to take dual gene therapies to treat aging. One of the ways was to use adeno-associated virus, called AAV. “AAV doesn't essentially do what old gene therapy does,” she explains. “So, you don't get sick when you take it, because if you get sick then you're going to not uptake the genes. … And viruses are still the best gene delivery method there is. They get genes into the nucleus.”
“Remember, these viruses are modifying you every year,” Liz says. “You get viruses and influenzas and things like that and they all do their little dance. We're just making them do a dance that only up-regulates therapeutic genes.”
From increased muscle mass to mitochondria, and from clinical trials to affordability, our conversation about gene therapy takes you into new territory. Listen on to learn more about Liz’s personal experience, her longevity work, and how you can shape your own genes.
Enjoy the show! And get more resources at Dave.Asprey/podcasts.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By Dave Asprey4.6
69326,932 ratings
In this episode of Bulletproof Radio, my guest is known as "the woman who wants to genetically engineer you," and a leading voice for genetic cures.
Liz Parrish founded and serves as CEO of BioViva Sciences USA Inc., a bioinformatics company actively working to extend healthy lifespans using gene therapy. It’s looking specifically at how gene therapy works in humans and how regenerative genes work in human bodies. Its partner company, Integrative Health Systems, helps people get access to these technologies today.
A strong champion of progress and education for the advancement of gene therapy, Liz firmly supports our right and our ability to hack our own DNA.
And she definitely walks her talk: In 2015 she became the first person in the world to take dual gene therapies to treat aging. One of the ways was to use adeno-associated virus, called AAV. “AAV doesn't essentially do what old gene therapy does,” she explains. “So, you don't get sick when you take it, because if you get sick then you're going to not uptake the genes. … And viruses are still the best gene delivery method there is. They get genes into the nucleus.”
“Remember, these viruses are modifying you every year,” Liz says. “You get viruses and influenzas and things like that and they all do their little dance. We're just making them do a dance that only up-regulates therapeutic genes.”
From increased muscle mass to mitochondria, and from clinical trials to affordability, our conversation about gene therapy takes you into new territory. Listen on to learn more about Liz’s personal experience, her longevity work, and how you can shape your own genes.
Enjoy the show! And get more resources at Dave.Asprey/podcasts.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

176 Listeners

770 Listeners

674 Listeners

4,583 Listeners

580 Listeners

364 Listeners

4,986 Listeners

7,279 Listeners

141 Listeners

717 Listeners

4,872 Listeners

3,457 Listeners

9,231 Listeners

1,829 Listeners

142 Listeners

2,560 Listeners

1,781 Listeners

840 Listeners

292 Listeners

1,196 Listeners

3,097 Listeners